Business Description
Algernon Health Inc. is a Canadian company that develops new medicines to treat serious conditions such as kidney disease, liver disease, and stroke. Founded in 2015 and based in Vancouver, the company also conducts research in Australia. Its current drug candidates include repirinast, aimed at chronic kidney disease, and DMT, being studied as a potential treatment for stroke and traumatic brain injury.
